Search clinical trials for: anlotinib AP/PC

Total 1770 results

University of Calgary
University of Alberta

Recruiting

Pharmacogenetic-Guided Antidepressant Prescribing in Adolescents (PGx-GAP)

Depression in Adolescence

Canada
The University of Texas Health Science Center,...
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

PRIME: PReservIng Memory in Epilepsy

Mesial Temporal Lobe Epilepsy

United States
Hunan Province Tumor Hospital

Not yet recruiting

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW (WUKONG-32-RW)

Non-small Cell Lung Cancer

China
Hunan Province Tumor Hospital

Not yet recruiting

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR-Sensitive Mutations Combined With Co-Mutations Advanced NSCLC (WUKONG-32)

Non-Small Cell Lung Cancer

China
Insulet Corporation

Completed

Insulet Artificial Pancreas Evaluating Meal Performance and Moderate Exercise (IDE2) (IDE2)

Type 1 Diabetes Mellitus

United States
Siegrist Claire-Anne
BioNet-Asia Co., Ltd.

Completed

The PertADO Geneva Trial

Pertussis

Switzerland
Peking Union Medical College Hospital

Not yet recruiting

Study of Anlotinib in Patients With Radioiodine Refractory Differentiated Thyroid Cancer

Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma

China
Li-kun Chen

Recruiting

the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer

Non-small Cell Lung Cancer | Brain Metastases

China
The First Affiliated Hospital of Zhengzhou University

Active, not recruiting

Anlotinib Combined With TQB2450 (PD-L1 Inhibitor) in the Treatment of Advanced Esophageal Squamous Cell Carcinoma(ESCC)

Esophageal Squamous Cell Carcinoma

China
Hubei Cancer Hospital

Recruiting

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

NSCLC

China
Amorepacific Corporation

Completed

Anti-pollution Effects of AP Green Tea Extracts

Respiratory Conditions Due to Unspecified External Agent

Korea, Republic of
Boston University Charles River Campus
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Mobile App-based Approach for Reducing Pain and Hazardous Drinking: a Pilot Study

Alcohol Drinking | Chronic Pain

United States
Fundació d'investigació Sanitària de les Illes...
Ministerio de Economía y Competitividad, Spain

Unknown

Improving Patient Safety in Spanish Primary Care (PC) Centres (SinergiAPS)

Patient Safety

Spain
Cancer Institute and Hospital, Chinese Academy...

Completed

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer
Peking University People's Hospital
Xingtai People's Hospital; Hebei Provincial People's Hospital

Not yet recruiting

Efficacy and Safety of an Artificial-pancreas-like Learning-based Control in Type 1 Diabetes on Multiple Daily Injection Therapy (ELITE)

Diabetes Mellitus, Type 1
Niguarda Hospital

Completed

Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells

Leukemia, Myeloid, Chronic-Phase

Italy
Novartis Pharmaceuticals

Terminated

Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

Switzerland, United States, Germany, Singapore, Korea, Republic of, Canada
Riphah International University

Completed

Mirror Therapy on PC in Acute Bell's Palsy.

Bell Palsy

Pakistan
Stanford University

Completed

Neural and Kinematic Features of Freezing of Gait for Adaptive Neurostimulation

Parkinson Disease

United States
The Hong Kong Polytechnic University

Not yet recruiting

Parent-Child Single-Session Growth Mindset Intervention on Adolescent Depression and Anxiety Problems

Depression, Anxiety
Santi Mangiafico

Not yet recruiting

Partially Covered Metal Stents Efficacy in Biliary Drainage of Malignant Extra-hepatic Biliary Obstruction (METARSI)

Biliary Obstruction
Chen Ling
Prince of Wales Hospital, Shatin, Hong Kong; Shenzhen Second People's Hospital

Completed

Early Versus Late Application of STN DBS to PD Patients With Motor Complications (ELASS)

Parkinson Disease

China
The First Affiliated Hospital with Nanjing Medical...

Unknown

Combination Chemotherapy With or Without Anlotinib in the Maintenance Treatment of Non-Squamous Non-Small Cell Lung Cancer.

Non-squamous Non-small-cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.

Hepatocellular Carcinoma

China
Peking University People's Hospital
Akeso Pharmaceuticals, Inc.

Not yet recruiting

Neoadjuvant Cadonilimab Combined With Anlotinib in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma
Anqin Zhang

Not yet recruiting

ADCb (Anlotinib/Docetaxel/Carboplatin) as Neoadjuvant Therapy for Triple-Negative Breast Cancer

Breast Cancer

China
Zhejiang Cancer Hospital

Completed

Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations

Lung Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Study of Anlotinib in Subjects With Advanced Malignancy

Advanced Malignancy

China
Tianjin Medical University Cancer Institute and...

Enrolling by invitation

Phase 2 Multi-center Randomized Study to the Efficacy and Safety of AK105 Combined With Anrotinib Hydrochloride in Patients With Recurrent/Refractory Classical Hodgkin's Lymphoma

Recurrent/Refractory Classical Hodgkin's Lymphoma

China
National Cancer Center, Korea
AstraZeneca

Unknown

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

Adenocarcinoma | Non Small Cell Lung Cancer

Korea, Republic of
Kunming Medical University

Recruiting

A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation

Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor

China
West China Hospital

Recruiting

PD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid Cancer

Thyroid Cancer

China
The First Affiliated Hospital of Xinxiang Medical...

Recruiting

Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients (AP)

Lung Cancer | Non Small Cell Lung Cancer | Lung Carcinoma | Non-small Cell Carcinoma | Lung Neoplasm

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer (TNBC)

China
China Medical University Hospital

Completed

The Effect of Probiotics on Type 1 Diabetes Mellitus in Children

Type 1 Diabetes Mellitus

Taiwan
Shanghai Zhongshan Hospital

Unknown

Study of Anlotinib After Lenvatinib in Patients With Hepatocellular Carcinoma (ALTER-H-002)

Hepatocellular Carcinoma

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma

Soft Tissue Sarcoma

China
Ji Yongling

Not yet recruiting

Radiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC

Non-Small Cell Lung Cancer
Azienda Ospedaliera Città della Salute e della...

Completed

Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool (SST2017)

Chronic Heart Failure | Metastatic Cancer | Chronic Respiratory Failure | Chronic Liver Failure | Chronic Renal Failure | Locally Advanced Cancer

Italy
University of Michigan
National Institute of Mental Health (NIMH)

Recruiting

Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers

PTSD

United States
Luca Marin

Enrolling by invitation

Pneumatic Compression Versus Anti-thromboembolic Exercises for Patients Undergoing Total Hip Arthroplasty

Edema Leg

Italy
Henan University of Traditional Chinese Medicine

Unknown

TCM in the Treatment of Lung Adenocarcinoma

Lung Adenocarcinoma
Chestnut Health Systems
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Recovery Management Checkups for Primary Care Experiment (RMC-PC)

Substance Use Disorders

United States
ConjuChem

Completed

A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy

Type 2 Diabetes Mellitus

Canada
Gazi University

Completed

Effect of Dose-dependent Platelet Rich Fibrin(PRF) (PRF)

Gingival Recession
University of California, Davis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Kaiser...

Enrolling by invitation

Study to Understand Risk Information to Support and Empower (SUNRISE)

Diabetes Mellitus, Type 2 | Diabetes, Gestational

United States
First Affiliated Hospital of Wenzhou Medical University
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Interstitial Lung Diseases

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of Anlotinib and AK105 Injection in Subjects With Advanced Head, Neck and Chest Cancer

Advanced Head, Neck and Chest Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors

Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma

Advanced Cholangiocarcinoma

China

Search clinical trials for: anlotinib AP/PC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations